These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Life-threatening bite injury of the lower lip after use of metamizole. Becker ST; Wiltfang J; Springer IN; Bartsch MS; Guenther R; Sherry E; Warnke PH Oral Maxillofac Surg; 2008 May; 12(1):39-41. PubMed ID: 18600360 [TBL] [Abstract][Full Text] [Related]
24. [Dual agranulocytosis episode likely resulting from metamizole use]. Hemmersbach-Miller M; Conde Martel A; Acosta Artiles M; Suárez Ortega S Farm Hosp; 2005 Mar; 29(2):148-50. PubMed ID: 16045431 [No Abstract] [Full Text] [Related]
25. [Clinical otorhinolaryngological symptoms of metamizole-induced agranulocytosis]. Send T; Westermann S; Eichhorn KW; Jakob M HNO; 2015 Mar; 63(3):215-9. PubMed ID: 25515122 [TBL] [Abstract][Full Text] [Related]
26. [A case of rheumatoid arthritis associated with agranulocytosis during bucillamine treatment]. Negishi M; Yamazaki J; Hosaka M; Iwabuchi H; Matsuda A; Kanemitsu H; Hiramatsu K; Kaga S; Hashimoto M; Kasama T Ryumachi; 1994 Jun; 34(3):651-5. PubMed ID: 8052932 [TBL] [Abstract][Full Text] [Related]
27. [Surgery, dipyrone, and agranulocytosis in Latin America]. Sánchez Medal L Sangre (Barc); 1997 Oct; 42(5):343-4. PubMed ID: 9424731 [No Abstract] [Full Text] [Related]
28. [Fatal Outcome of Agranulocytosis after Re-Exposure to Metamizole and Cefepime-Induced Encephalopathy]. Skaistys A; Rätz Bravo AE; Leuppi-Taegtmeyer A; Zysset Y Praxis (Bern 1994); 2019 Aug; 108(10):693-697. PubMed ID: 31387493 [TBL] [Abstract][Full Text] [Related]
29. The incidence of metamizole sodium-induced agranulocytosis in Poland. Maj S; Lis Y J Int Med Res; 2002; 30(5):488-95. PubMed ID: 12449518 [TBL] [Abstract][Full Text] [Related]
35. Fournier's gangrene after hemorrhoidectomy: association with drug-induced agranulocytosis. Report of a case. Cihan A; Menteş BB; Sucak G; Karamercan A; Naznedar R; Ferahköşe Z Dis Colon Rectum; 1999 Dec; 42(12):1644-8. PubMed ID: 10613488 [TBL] [Abstract][Full Text] [Related]
36. [Fatal agranulocytosis after metamizole reexposure]. Zeiner E; Blaser LS; Tisljar K; Heim D; Taegtmeyer A Praxis (Bern 1994); 2015 Jan; 104(3):151-4. PubMed ID: 25626384 [TBL] [Abstract][Full Text] [Related]
37. [Agranulocytosis and metamizole]. Hoerder U; König HJ; Hartwich G Dtsch Med Wochenschr; 1982 Dec; 107(50):1923-6. PubMed ID: 7140576 [TBL] [Abstract][Full Text] [Related]
38. Dipyrone (metamizole) use in the United States: a lethal tango? Moorman J South Med J; 2006 Sep; 99(9):916. PubMed ID: 17004522 [No Abstract] [Full Text] [Related]
39. [Metamizole (dipyrone): mode of action, drug-drug interactions, and risk of agranulocytosis]. Lampl C; Likar R Schmerz; 2014 Dec; 28(6):584-90. PubMed ID: 25199942 [TBL] [Abstract][Full Text] [Related]
40. Agranulocytosis attributed to metamizole: An analysis of spontaneous reports in EudraVigilance 1985-2017. Hoffmann F; Bantel C; Jobski K Basic Clin Pharmacol Toxicol; 2020 Feb; 126(2):116-125. PubMed ID: 31449718 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]